Polymer particles bearing recombinant lel cd81 as trapping systems for hepatitis c virus. / Polyakov, Dmitry; Sinitsyna, Ekaterina; Grudinina, Natalia; Antipchik, Mariia; Sakhabeev, Rodion; Korzhikov-Vlakh, Viktor; Shavlovsky, Mikhail; Korzhikova-Vlakh, Evgenia; Tennikova, Tatiana.
In: Pharmaceutics, Vol. 13, No. 5, 672, 07.05.2021.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Polymer particles bearing recombinant lel cd81 as trapping systems for hepatitis c virus
AU - Polyakov, Dmitry
AU - Sinitsyna, Ekaterina
AU - Grudinina, Natalia
AU - Antipchik, Mariia
AU - Sakhabeev, Rodion
AU - Korzhikov-Vlakh, Viktor
AU - Shavlovsky, Mikhail
AU - Korzhikova-Vlakh, Evgenia
AU - Tennikova, Tatiana
N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/5/7
Y1 - 2021/5/7
N2 - Hepatitis C is one of the most common social diseases in the world. The improvements in both the early diagnostics of the hepatitis C and the treatment of acute viremia caused by hepatitis C virus are undoubtedly an urgent task. In present work, we offered the micro-and nanotraps for the capturing of HCV. As a capturing moiety, we designed and synthesized in E. coli a fusion protein consisting of large extracellular loop of CD81 receptor and streptavidin as spacing part. The obtained protein has been immobilized on the surface of PLA-based micro-and nanoparticles. The developed trapping systems were characterized in terms of their physico-chemical properties. In order to illustrate the ability of developed micro-and nanotraps to bind HCV, E2 core protein of HCV was synthesized as a fusion protein with GFP. Interaction of E2 protein and hepatitis C virus-mimicking particles with the developed trapping systems were testified by several methods.
AB - Hepatitis C is one of the most common social diseases in the world. The improvements in both the early diagnostics of the hepatitis C and the treatment of acute viremia caused by hepatitis C virus are undoubtedly an urgent task. In present work, we offered the micro-and nanotraps for the capturing of HCV. As a capturing moiety, we designed and synthesized in E. coli a fusion protein consisting of large extracellular loop of CD81 receptor and streptavidin as spacing part. The obtained protein has been immobilized on the surface of PLA-based micro-and nanoparticles. The developed trapping systems were characterized in terms of their physico-chemical properties. In order to illustrate the ability of developed micro-and nanotraps to bind HCV, E2 core protein of HCV was synthesized as a fusion protein with GFP. Interaction of E2 protein and hepatitis C virus-mimicking particles with the developed trapping systems were testified by several methods.
KW - Interaction of LEL CD81 with E2 protein
KW - Poly(lactic acid)-based micro-and nanoparticles
KW - Recombinant CD81-streptavidin fusion protein
KW - Trapping system for HCV
KW - Virus-mimicking particles
KW - recombinant CD81-streptavidin fusion protein
KW - SIZE
KW - NANOTRAP
KW - ENVELOPE PROTEINS
KW - IDENTIFICATION
KW - E2
KW - virus-mimicking particles
KW - NANOPARTICLES
KW - trapping system for HCV
KW - poly(lactic acid)-based micro- and nanoparticles
KW - PURIFICATION
KW - interaction of LEL CD81 with E2 protein
KW - ALBUMIN
KW - MICRO
KW - EXPRESSION
UR - http://www.scopus.com/inward/record.url?scp=85106472030&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/3758d17d-e291-39c2-8f40-b16acaabc5c8/
U2 - 10.3390/pharmaceutics13050672
DO - 10.3390/pharmaceutics13050672
M3 - Article
AN - SCOPUS:85106472030
VL - 13
JO - Pharmaceutics
JF - Pharmaceutics
SN - 1999-4923
IS - 5
M1 - 672
ER -
ID: 83919888